ORTHO EVRA and venous thromboembolism: an update
Jick, S.S.; Hagberg, K.W.; Kaye, J.A.
Contraception 81(5): 452-453
2010
ISSN/ISBN: 0010-7824 PMID: 20399954 DOI: 10.1016/j.contraception.2009.12.016Document Number: 222376
Document emailed within 0-6 h
Related Documents
Jick, S.S.; Hagberg, K.W.; Hernandez, R.K.; Kaye, J.A. 2010: Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism Contraception 81(1): 16-21Sibai, B.M.; Odlind, V.; Meador, M.L.; Shangold, G.A.; Fisher, A.C.; Creasy, G.W. 2002: A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra) Fertility and Sterility 77(2 Suppl 2: S19-S26
Archer, D.F.; Bigrigg, A.; Smallwood, G.H.; Shangold, G.A.; Creasy, G.W.; Fisher, A.C. 2002: Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women Fertility and Sterility 77(2 Suppl. 2): S27-S31
Harel, Z.; Riggs, S.; Vaz, R.; Flanagan, P.; Dunn, K.; Harel, D. 2005: Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra Journal of Pediatric and Adolescent Gynecology 18(2): 85-90
Trujillo-de Santiago, G.; Patricio Sáenz-Collins, C.; García-Arellano, L.; Moisés Álvarez, M. 2014: Mathematical modeling of the release of active ingredients from a contraceptive patch: ortho evra(®) as a case study Iranian Journal of Pharmaceutical Research: Ijpr 13(1): 39-48
Plu-Bureau, G.; Maitrot-Mantelet, L.; Hugon-Rodin, J.; Canonico, M. 2013: Hormonal contraceptives and venous thromboembolism: an epidemiological update Best Practice and Research. Clinical Endocrinology and Metabolism 27(1): 25-34
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Liu, F-fang.; Zhai, Z-guo.; Yang, Y-hua.; Wang, J.; Wang, C. 2013: Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93(24): 1860-1863
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Gaspard, U. 2003: Le médicament du mois : Evra® : premier patch pour la contraception transdermique - Evra® : First transdermal patch for contraception Rmlg. Revue Medicale de Liege 58(11): 709-712
Vasilenko, N.M.; Labunskiĭ, V.V. 1971: Comparative toxicological characteristics of para- and ortho-aminophenols, para-chloro-ortho-aminophenol and para-nitro-ortho-aminophenol Farmakologiia i Toksikologiia 34(6): 730-733
Láznícek, M.; Kvĕtina, J.; Mazák, J.; Krch, V.; Kvĕtinová, M.; Srámek, B. 1987: Changes in plasma binding of ortho-iodobenzoate and ortho-iodohippuran in patients with kidney and liver diseases Ceskoslovenska Farmacie 36(3): 97-102
Chunilal, S.D.; Brill-Edwards, P.A.; Stevens, P.B.; Joval, J.P.; McGinnis, J.A.; Rupwate, M.; Ginsberg, J.S. 2002: The sensitivity and specificity of a red blood cell agglutination D-dimer assay for venous thromboembolism when performed on venous blood Archives of Internal Medicine 162(2): 217-220
Pershin, S.M. 2010: Weak coherent radiation of OH and ortho- H2O space masers as a carrier in biocommunication: the ortho/para-conversion of H2O spin isomers? Biofizika 55(4): 619-625
Sander, R.W.; Flynn, C.A. 1998: Venous thromboembolism and cancer Journal of Family Practice 47(1): 13-14